Septin 9 Methylated DNA Is a Sensitive and Specific Blood Test for Colorectal Cancer

BMC Medicine - United Kingdom
doi 10.1186/1741-7015-9-133
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Septin-9: A Novel Biomarker for Colorectal Cancer Screening

International Surgery Journal
2019English

Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients With Colorectal Cancer After Surgery

Scientific Reports
Multidisciplinary
2019English

Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer

JCO Precision Oncology
Cancer ResearchOncology
2019English

What Is a Reasonable Screening Test for Colorectal Cancer

Journal of the Korean Society of Coloproctology
2010English

Circulating Cell-Free Methylated DNA and Lactate Dehydrogenase Release in Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Decreased Expression of Chromodomain Helicase DNA-binding Protein 9 Is a Novel Independent Prognostic Biomarker for Colorectal Cancer

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2018English

Heightened Peripheral Blood Lymphocyte CD69 Expression Is Neither Sensitive Nor Specific as a Noninvasive Diagnostic Test for Renal Allograft Rejection

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2003English

TMEM25Is a Candidate Biomarker Methylated and Down-Regulated in Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy